DocGo Inc. (NASDAQ:DCGO) Given Consensus Recommendation of “Hold” by Brokerages

Shares of DocGo Inc. (NASDAQ:DCGO) have been given an average rating of “Hold” by the six analysts that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $2.3750.

DCGO has been the topic of several research reports. Cantor Fitzgerald restated an “overweight” rating on shares of DocGo in a research report on Monday, May 11th. Needham & Company LLC restated a “buy” rating and issued a $3.00 price target on shares of DocGo in a research report on Tuesday, March 17th. Stifel Nicolaus reduced their price target on shares of DocGo from $4.00 to $2.50 and set a “buy” rating on the stock in a research report on Tuesday, March 17th. Wall Street Zen upgraded shares of DocGo from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Finally, Canaccord Genuity Group reduced their price target on shares of DocGo from $1.50 to $1.00 and set a “hold” rating on the stock in a research report on Wednesday, March 25th.

DocGo Stock Performance

Shares of DCGO opened at $0.57 on Thursday. The company’s fifty day moving average is $0.61 and its 200 day moving average is $0.73. DocGo has a fifty-two week low of $0.49 and a fifty-two week high of $1.78. The stock has a market capitalization of $55.91 million, a PE ratio of -0.30 and a beta of 1.00.

DocGo (NASDAQ:DCGO) last announced its quarterly earnings results on Monday, May 11th. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.10). DocGo had a negative return on equity of 44.09% and a negative net margin of 62.23%.The business had revenue of $75.55 million during the quarter, compared to the consensus estimate of $72.48 million. As a group, research analysts forecast that DocGo will post -0.12 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Geode Capital Management LLC boosted its stake in DocGo by 3.4% during the fourth quarter. Geode Capital Management LLC now owns 2,259,901 shares of the company’s stock worth $1,984,000 after buying an additional 73,900 shares during the period. State Street Corp boosted its stake in DocGo by 2.0% during the fourth quarter. State Street Corp now owns 1,969,603 shares of the company’s stock worth $1,729,000 after buying an additional 39,125 shares during the period. Renaissance Technologies LLC boosted its stake in DocGo by 167.1% during the first quarter. Renaissance Technologies LLC now owns 1,510,361 shares of the company’s stock worth $950,000 after buying an additional 944,826 shares during the period. Isthmus Partners LLC boosted its stake in DocGo by 14.0% during the first quarter. Isthmus Partners LLC now owns 1,013,056 shares of the company’s stock worth $637,000 after buying an additional 124,211 shares during the period. Finally, Goldman Sachs Group Inc. boosted its stake in DocGo by 205.4% during the fourth quarter. Goldman Sachs Group Inc. now owns 805,427 shares of the company’s stock worth $707,000 after buying an additional 541,670 shares during the period. 56.44% of the stock is owned by hedge funds and other institutional investors.

DocGo Company Profile

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.